| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 607183 | 83925 | LIDOCAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG | LIDOCAINA KABI 10 MG/ML SOLUCION INYECTABLE EFG, 100 ampollas x 10 ml | 10 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas x 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83925/83925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83925/83925_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2019-03-12 | 1 | 1 | 1 | 2019-03-13 | 2019-03-12 | 1 | 2020-03-26 | View Edit Delete | ||||||||||||
| 607185 | 83934 | LIDOCAINA KABI 20 MG/ML SOLUCION INYECTABLE EFG | LIDOCAINA KABI 20 MG/ML SOLUCION INYECTABLE EFG, 100 ampollas x 5 ml | 20 mg/ml inyectable 5 ml | 1 | 100 | 1 | 100 ampollas x 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83934/83934_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83934/83934_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2019-03-12 | 1 | 1 | 1 | 2019-03-13 | 2019-03-12 | 1 | 2021-10-26 | View Edit Delete | ||||||||||||
| 607186 | 83934 | LIDOCAINA KABI 20 MG/ML SOLUCION INYECTABLE EFG | LIDOCAINA KABI 20 MG/ML SOLUCION INYECTABLE EFG, 100 ampollas x 10 ml | 20 mg/ml inyectable 10 ml | 1 | 100 | 1 | 100 ampollas x 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83934/83934_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83934/83934_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2019-03-12 | 1 | 1 | 1 | 2019-03-13 | 2019-03-12 | 1 | 2020-03-31 | View Edit Delete | ||||||||||||
| 607340 | 83282 | OXITOCINA KABI 10 UI/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | OXITOCINA KABI 10 UI/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 10 ampollas de 1 ml | 10 UI/ml inyectable 1 ml | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83282/83282_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83282/83282_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2018-11-21 | 1 | 1 | 1 | 2018-11-21 | 2020-03-30 | 1 | 2021-05-14 | View Edit Delete | ||||||||||||
| 617225 | 51345 | ALGI-MABO 0,4 G/ML SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN | ALGI-MABO 0,4 G/ML SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN 100 ampollas de 5 ml | 2.000 mg | 1 | 100 | 1 | 100 ampollas de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/51345/51345_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/51345/51345_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 1973-06-01 | 1 | 1 | 1 | 1973-06-01 | 1973-06-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 622100 | 53939 | AMCHAFIBRIN 500 mg SOLUCION INYECTABLE | AMCHAFIBRIN 500 mg SOLUCION INYECTABLE, 100 ampollas de 5 ml | 500 mg inyectable 5 ml | 1 | 100 | 1 | 100 ampollas de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53939/53939_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53939/53939_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 1980-01-01 | 1 | 1 | 1 | 1980-01-01 | 1981-07-01 | 0 | 2011-02-11 | View Edit Delete | ||||||||||||
| 620146 | 65237 | ACICLOVIR TEDEC 25 mg/ml SOLUCION PARA PERFUSION EFG | ACICLOVIR TEDEC 25 mg/ml SOLUCION PARA PERFUSION EFG , 50 ampollas de 10 ml | 250 mg | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65237/65237_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65237/65237_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 32379 | MEIJI PHARMA SPAIN S.A. | 2003-02-24 | 1 | 1 | 1 | 2003-02-24 | 2003-02-24 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 607371 | 57109 | BUPIVACAINA PHYSAN 2,5 MG/ML SOLUCION INYECTABLE | BUPIVACAINA PHYSAN 2,5 MG/ML SOLUCION INYECTABLE 50 ampollas de 10 ml | 2,5 mg/ml inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57109/57109_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57109/57109_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 2020-09-30 | 1 | 2021-08-30 | View Edit Delete | ||||||||||||
| 607372 | 57110 | BUPIVACAINA PHYSAN 5 MG/ML SOLUCIÓN INYECTABLE | BUPIVACAINA PHYSAN 5 MG/ML SOLUCIÓN INYECTABLE 50 ampollas de 10 ml | 5 mg/ml inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57110/57110_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57110/57110_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 2020-09-30 | 1 | 2021-07-20 | View Edit Delete | ||||||||||||
| 607373 | 58023 | BUPIVACAINA PHYSAN 7,5 MG/ML SOLUCIÓN INYECTABLE | BUPIVACAINA PHYSAN 7,5 MG/ML SOLUCIÓN INYECTABLE 50 ampollas de 10 ml | 7,5 mg/ml inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58023/58023_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58023/58023_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1989-10-01 | 1 | 1 | 1 | 1989-10-01 | 2020-09-30 | 1 | 2021-08-30 | View Edit Delete | ||||||||||||
| 607375 | 45668 | BUPIVACAÍNA/ADRENALINA PHYSAN 2,5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE | BUPIVACAÍNA/ADRENALINA PHYSAN 2,5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE, 50 ampollas de 10 ml | 2,5 mg/ml + 5 microgramos/ml inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/45668/45668_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/45668/45668_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1968-04-01 | 1 | 1 | 1 | 1968-04-01 | 2020-09-30 | 1 | 2022-07-07 | View Edit Delete | ||||||||||||
| 607376 | 45669 | BUPIVACAÍNA/ADRENALINA PHYSAN 5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE | BUPIVACAÍNA/ADRENALINA PHYSAN 5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLE, 50 ampollas de 10 ml | 5 mg/ml + 5 microgramos/ml inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/45669/45669_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/45669/45669_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1968-04-01 | 1 | 1 | 1 | 1968-04-01 | 2020-09-30 | 1 | 2022-07-07 | View Edit Delete | ||||||||||||
| 607377 | 58023 | BUPIVACAINA PHYSAN 7,5 MG/ML SOLUCIÓN INYECTABLE | BUPIVACAINA PHYSAN 7,5 MG/ML SOLUCIÓN INYECTABLE 50 ampollas de 2 ml | 7,5 mg/ml inyectable 2 ml | 1 | 50 | 1 | 50 ampollas de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58023/58023_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58023/58023_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1989-10-01 | 1 | 1 | 1 | 1989-10-01 | 2020-10-02 | 1 | 2023-12-15 | View Edit Delete | ||||||||||||
| 607378 | 62168 | FUROSEMIDA PHYSAN 20mg/2ml SOLUCIÓN INYECTABLE EFG | FUROSEMIDA PHYSAN 20mg/2ml SOLUCIÓN INYECTABLE EFG,50 ampollas de 2 ml | 20 mg | 1 | 50 | 1 | 50 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62168/62168_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62168/62168_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1998-07-01 | 1 | 1 | 1 | 2020-08-11 | 2020-10-07 | 1 | 2021-04-06 | View Edit Delete | ||||||||||||
| 607379 | 37726 | MEPIVACAINA PHYSAN 10 mg/ml SOLUCION INYECTABLE | MEPIVACAINA PHYSAN 10 mg/ml SOLUCION INYECTABLE, 50 ampollas de 10 ml | 10 mg/ml inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/37726/37726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/37726/37726_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1962-05-01 | 1 | 1 | 1 | 1962-05-01 | 2020-10-07 | 1 | 2021-07-20 | View Edit Delete | ||||||||||||
| 607380 | 37725 | MEPIVACAINA PHYSAN 20 mg/ml SOLUCION INYECTABLE | MEPIVACAINA PHYSAN 20 mg/ml SOLUCION INYECTABLE,50 ampollas de 2 ml | 20 mg/ml inyectable 2 ml | 1 | 50 | 1 | 50 ampollas de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/37725/37725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/37725/37725_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1962-05-01 | 1 | 1 | 1 | 1962-05-01 | 2020-10-07 | 1 | 2021-08-30 | View Edit Delete | ||||||||||||
| 607381 | 37725 | MEPIVACAINA PHYSAN 20 mg/ml SOLUCION INYECTABLE | MEPIVACAINA PHYSAN 20 mg/ml SOLUCION INYECTABLE,50 ampollas de 10 ml | 200 mg inyectable 10 ml | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/37725/37725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/37725/37725_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 44420 | LAPHYSAN S.A.U. | 1962-05-01 | 1 | 1 | 1 | 1962-05-01 | 2020-10-07 | 1 | 2021-07-30 | View Edit Delete | ||||||||||||
| 607722 | 89081 | DAGESIL 75 MG/3 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | DAGESIL 75 MG/3 ML SOLUCION INYECTABLE Y PARA PERFUSION EFG, 50 ampollas de 3 ml | 75 mg inyectable 3 ml | 1 | 50 | 1 | 50 ampollas de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89081/89081_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89081/89081_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 42164 | LAPHYSAN S.A.U. | 2023-10-09 | 1 | 1 | 1 | 2023-10-10 | 2023-10-09 | 1 | 2024-03-21 | View Edit Delete | ||||||||||||
| 607755 | 89204 | TRAMADOL BASI 50 MG/ML SOLUCIÓN INYECTABLE EFG | TRAMADOL BASI 50 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 2 ml | 100 mg inyectable 2 ml | 1 | 50 | 1 | 50 ampollas de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89204/89204_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89204/89204_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 42164 | LAPHYSAN S.A.U. | 2023-12-20 | 1 | 1 | 1 | 2023-12-21 | 2023-12-20 | 1 | 2024-10-10 | View Edit Delete | ||||||||||||
| 607792 | 89559 | DIAZEPAM BASI 5 MG/ML SOLUCIÓN INYECTABLE EFG | DIAZEPAM BASI 5 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 2 ml | 10 mg inyectable 2 ml | 1 | 50 | 1 | 50 ampollas de 2 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89559/89559_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89559/89559_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 42164 | LAPHYSAN S.A.U. | 2024-05-13 | 1 | 1 | 1 | 2024-05-14 | 2024-05-13 | 1 | 2025-06-13 | Lista IV | View Edit Delete |
Page 25 of 1036, showing 20 records out of 20715 total, starting on record 481, ending on 500